Cas:129644-57-1 2-hydroxy-5-(trifluoromethoxy)benzoic acid manufacturer & supplier

We serve Chemical Name:2-hydroxy-5-(trifluoromethoxy)benzoic acid CAS:129644-57-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-hydroxy-5-(trifluoromethoxy)benzoic acid

Chemical Name:2-hydroxy-5-(trifluoromethoxy)benzoic acid
CAS.NO:129644-57-1
Synonyms:5-(trifluoromethoxy)salicylic acid;2-hydroxy-5-trifluoromethoxy-benzoic acid;MFCD01091003
Molecular Formula:C8H5F3O4
Molecular Weight:222.11800
HS Code:2918990090

Physical and Chemical Properties:
Melting point:130-132
Boiling point:291.7ºC at 760 mmHg
Density:1.577g/cm3
Index of Refraction:1.511
PSA:66.76000
Exact Mass:222.01400
LogP:1.98900

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-(trifluoromethoxy)salicylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01091003 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-hydroxy-5-trifluoromethoxy-benzoic acid Use and application,MFCD01091003 technical grade,usp/ep/jp grade.


Related News: As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 2-hydroxy-5-(trifluoromethoxy)benzoic acid manufacturer Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 2-hydroxy-5-(trifluoromethoxy)benzoic acid supplier In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said. 2-hydroxy-5-(trifluoromethoxy)benzoic acid vendor With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. 2-hydroxy-5-(trifluoromethoxy)benzoic acid factory Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology.